Canada Prostate Cancer Market Analysis

$3,000.00$7,500.00

  • Type: Oncology area
  • Published : April 2021
  • Region: North America
  • Country: Canada
  • Report ID : 3036

  • Format: PPT, PDF

Canadian Prostate Cancer Drugs Market: Segmented by Drug Class (Chemotherapy, Biological Therapy, Hormone Therapy, & Others), by Distribution (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, & Others)- Growth, Trends, and Forecasts (2019 – 2028)

Clear
SKU: 3036 Categories: ,

Report Overview

The Canadian Prostate Cancer drugs market size stood at around USD 110 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Prostate cancer is the most common type of cancer in Canadian men, followed by colorectal, lung, and bladder cancers. It is 3rd leading cause of death from cancer in men in Canada. Recent analyses from the Canadian Cancer Society suggest that 1 in 7 men will be diagnosed with prostate cancer in their lifetime and that 1 in 29 will die from the disease. Prostate cancer develops when abnormal cells in the prostate gland are forming a malignant tumor in an uncontrolled way. In 2020, an estimated 23,300 new cases of prostate cancer were diagnosed in Canada. Early (localized) prostate cancer refers to cancer cells that have grown but do not appear to have spread beyond the prostate.

Market Drivers

The rise in prevalence of Prostate Cancer, growing awareness about various types of Cancers, Advancements in the Healthcare Field are major market drivers for the Prostate cancer drugs market in Canada, it is the most common cancer diagnosed in men in Canada and the 3rd most common cause of cancer death in men. On average, 64 Canadian men will be diagnosed with prostate cancer, and 11 Canadian men will die from prostate cancer every day. The prostate cancer market has a high demand for novel drugs that concentrate on unmet needs, such as improved survival time, less toxicity, better progression-free survival, improved effectiveness, and lesser cost. Altering lifestyle, technological advancements in researching for new techniques to fight prostate cancer, increase in the funding in both the public and private sectors in the field of drug advancement are some of the key reasons driving the growth of the Canadian prostate cancer market.

1. Canadian Prostate Cancer Market Overview…………………………………
A. Market Size
2. Market Growth Drivers…………………………………………….……………………….
A. The rise in prevalence of Prostate Cancer
B. Growing awareness about various types of Cancer
C. Advancements in the healthcare field
3. Major Prostate Cancer…………………………………………………….…
A. Acinar Adenocarcinoma
B. Ductal Adenocarcinoma
C. Transitional Cell Cancer
D. Others
4. Prostate Cancer Market Segmentation…………………………………………
A. Drug Type
I. Chemotherapy
II. Biological Therapy
III. Hormone Therapy
IV. Radiation Therapy
V. Others
B. Distribution
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
5. Prostate Cancer Drugs Major Products Market Share…………………….…………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape……………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Sanofi overview, Product & Services, Strategies & Financials
B. AstraZeneca overview, Product & Services, Strategies & Financials
C. Roche AG overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Prostate Cancer Drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Type:

Based on drug type, the market is categorized into chemotherapy, biological therapy, and hormone therapy. Presently hormone therapy dominates the prostate cancer treatment market and is anticipated to continue this trend throughout the forecast period. The key factors that drive the market growth include an increase in the prevalence of prostate cancer, surge in demand for hormone therapy drugs, availability of generic drugs, rise in geriatric population, increase in the number of pharmaceutical companies, and rise in public awareness toward prostate cancer treatment.

By Distribution:

Based on the distribution channel, the market is divided into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. Currently, the hospital pharmacies segment accounted for the majority of prostate cancer treatment market share, owing to the strong presence of hospital pharmacies, increase in the number of hospitalized prostate cancer patients, and convenience offered by hospital pharmacies. Online pharmacies are the fastest-growing segment during the forecast period, owing to a rise in awareness regarding online pharmacies, an increase in the number of internet users, and a surge in preference for online purchasing of drugs over the traditional methods.

Major Players

Canada presents lucrative opportunities for the key players operating in the prostate cancer treatment market, owing to growth in awareness about prostate cancer treatment and the rise in adoption of prostate cancer treatment products. Moreover, improvement in healthcare infrastructure, rise in the number of hospitals equipped with advanced medical facilities, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare further contribute to the market growth.

Recently, Health Canada has approved AstraZeneca’s and Merck’s jointly developed Lynparza (olaparib) for the treatment of men with a specific form of mutated metastatic castration-resistant prostate cancer. In 2019, the Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada, following a Priority Review, has approved ERLEADA® (apalutamide) for the treatment of patients with metastatic castration-sensitive prostate cancer.

Key players profiled in this report include Sanofi, AstraZeneca plc, Bayer AG, Roche AG, GlaxoSmithKline Plc, Ipsen Pharma, Johnson & Johnson, etc.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements